Search - tctmd.com

Displaying 41 - 60 of 87

Sort: Relevancy | Date

News Daily News

Latest Statin Risk-Benefit Analysis: More Harm Than Good?

Yael L. Maxwell

July 15, 2021

News Daily News

Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI

Yael L. Maxwell

April 09, 2021

News Conference News AHA 2020

Black, Hispanic Individuals Bear Pandemic’s Brunt: AHA COVID-19 CVD Registry

Todd Neale

November 18, 2020

News Daily News

Nationwide Data Shed Light on Timing, Predictors of Acute MI in Pregnancy

Caitlin E. Cox

November 03, 2020

News Conference News HFSA 2020

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

L.A. McKeown

October 12, 2020

News Daily News

Influenza and Acute CV Events Can Go Hand in Hand

Caitlin E. Cox

August 25, 2020

News Conference News ACC 2020

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Michael O'Riordan

April 02, 2020

News Daily News

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Caitlin E. Cox

December 11, 2019

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Todd Neale

December 10, 2019

News Daily News

Nighttime Hypertension Drug Dosing May Reduce Risk of CVD

L.A. McKeown

October 23, 2019

News Conference News SCAI 2019

LDL Apheresis Potentially a ‘Head Start’ to Conventional Lipid-Lowering Methods Post-PCI in ACS: PREMIER

Yael L. Maxwell

June 03, 2019

News Conference News EAS 2019

Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients

Michael O'Riordan

May 30, 2019

News Daily News

Bempedoic Acid Boosts LDL Cholesterol-Lowering in Statin-Treated CVD Patients: CLEAR Harmony

Michael O'Riordan

March 15, 2019

News Features

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Michael O'Riordan

February 01, 2019

News Daily News

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

Michael O'Riordan

December 03, 2018

News Conference News EAS 2018

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

Yael L. Maxwell

May 11, 2018

News Daily News

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Yael L. Maxwell

April 18, 2018

News Daily News

No Increase in Long-term Cardiac Mortality After PCI for Women Compared With Men

L.A. McKeown

March 21, 2018

News Conference News ACC 2018

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Michael O'Riordan

March 20, 2018

News Daily News

AAFP Says It Cannot Endorse New Hypertension Guideline

Todd Neale

December 18, 2017

Advertisement

Latest Statin Risk-Benefit Analysis: More Harm Than Good?

Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI

Black, Hispanic Individuals Bear Pandemic’s Brunt: AHA COVID-19 CVD Registry

Nationwide Data Shed Light on Timing, Predictors of Acute MI in Pregnancy

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

Influenza and Acute CV Events Can Go Hand in Hand

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Nighttime Hypertension Drug Dosing May Reduce Risk of CVD

LDL Apheresis Potentially a ‘Head Start’ to Conventional Lipid-Lowering Methods Post-PCI in ACS: PREMIER

Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients

Bempedoic Acid Boosts LDL Cholesterol-Lowering in Statin-Treated CVD Patients: CLEAR Harmony

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

No Increase in Long-term Cardiac Mortality After PCI for Women Compared With Men

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

AAFP Says It Cannot Endorse New Hypertension Guideline

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content